Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

“Despite everything—politics, diplomacy, war—Israel has always maintained a gold-plated reputation as one of the best places ...

Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) reported record revenue and a lower net loss for the second quarter of its fiscal year.

Pharmatrust Professional College has held its 21st Graduation and Matriculation Ceremony, marking a historic milestone in the school’s journey of excellence ...

The September quarter earnings season is drawing to a close and the final trading day of the week will see more announcements ...

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Editor's note: this interview was originally published on BioPharmInternational.com.

Q3 2025 Earnings Call November 6, 2025 4:30 PM ESTCompany ParticipantsStephen Silvestro - President & CEOEdward Stelmakh ...

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the ...

The robust 77.8% three-month CR rate observed in the UTOPIA trial is highly encouraging and reinforces the potential of UGN-103 to deliver meaningful benefits to patients,” said Liz Barrett, President ...

Standard Glass Lining Technology Limited Announces Strong Q2 FY26 Performance and Strategic Transformation into a High- Precision Engineering Powerhouse ...